
KEY ABSTRACT DEADLINES
Abstract submissions are open for both conferences — please help us spread the word before these dates:
- HIV Persistence 2026 — abstract deadline August 21, 2026. Submit oral & poster abstracts at www.hivpersistence.com/abstracts
- Respi-DART 2026 — late-breaking abstract deadline September 17, 2026. Submit via respidart.com/abstracts
A MUTUAL PARTNERSHIP
In gratitude for your endorsement, we are delighted to promote your organization to the combined community of HIV Persistence and Respi-DART attendees, exhibitors, and mailing list subscribers — HIV researchers, respiratory virologists, clinicians, and public health professionals worldwide.
Please let us know if your organization has specific format preferences for posting or sharing information — we are happy to adapt materials as needed.
WHAT’S INSIDE THIS KIT
- Key abstract deadlines for both conferences, highlighted up front
- Conference highlights for both HIV Persistence 2026 and Respi-DART 2026
- A combined email newsletter template promoting both conferences and both abstract deadlines, with clickable links
- Social media templates for X (Twitter), LinkedIn, Facebook, and Instagram — per-conference sets, plus combined posts promoting both meetings together
- Call-for-abstracts templates with each conference’s submission deadline
- Tips for sharing, tagging, and pasting cleanly
HIV Persistence 2026
December 6–9, 2026 • Hacienda del Mar Resort, Los Cabos, Mexico • www.hivpersistence.com
Abstract deadline: August 21, 2026 — oral and poster submissions at www.hivpersistence.com/abstracts
- Focus on cutting-edge HIV reservoir biology, virology, and immunology
- Sessions on novel therapeutics: latency reversal, block-and-lock, bNAbs, gene/CAR-T, lenacapavir-class agents
- Clinical studies on ATIs, biomarkers, post-treatment control, and pediatric cure research
- Abstract-driven program with priority given to young and early-career investigators; scholarships available
- New this year: first-of-its-kind partnership with HIV-DART
Respi-DART 2026
December 9–11, 2026 • Hacienda del Mar Resort, Los Cabos, Mexico • registration and abstracts via respidart.com
Late-breaking abstract deadline: September 17, 2026 — submit at respidart.com/abstracts
- Focus on drug discovery and antiviral development for respiratory and re-emerging viruses
- Sessions on RSV, influenza, long COVID, and pandemic preparedness
- Coverage of emerging and re-emerging threats: dengue, chikungunya, yellow fever, Nipah, norovirus
- Gertrude Elion DART Achievement Award session honoring leaders in antiviral science
- Dedicated Industry Session and abstract slots reserved for early-career investigators